Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00002124
What this trial is testing

A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3

Who this might be right for
HIV Infections
Pharmacia and Upjohn 1,250
Large-scale testing (Phase 3)Active Not RecruitingNCT02881320
What this trial is testing

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1

Who this might be right for
HIV-1 Infection
Gilead Sciences 177
Large-scale testing (Phase 3)Study completedNCT02792088
What this trial is testing

Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside Analogues

Who this might be right for
Chronic Hepatitis B
IlDong Pharmaceutical Co Ltd 146
Testing effectiveness (Phase 2)Study completedNCT01302847
What this trial is testing

Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 181
Early research (Phase 1)Ended earlyNCT01586325
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of JNJ-47910382 at Different Doses and Dose Regimens in Asian Genotype-1, Chronic, HCV-Infected Patients

Who this might be right for
Chronic Hepatitis C Infection
Janssen R&D Ireland 8
Early research (Phase 1)Study completedNCT00000876
What this trial is testing

Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Very early researchStudy completedNCT03188276
What this trial is testing

The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 52
Large-scale testing (Phase 3)Looking for participantsNCT07016321
What this trial is testing

Emetine for Viral Outbreaks (a.k.a. EVOLVE Antiviral Initiative)

Who this might be right for
Dengue
Johns Hopkins University 600
Not applicableStudy completedNCT04330508
What this trial is testing

Effects of Direct-acting Antiviral Agents on HCV Cognitive Function, and Depression in HCV Related Cirrhosis: A Prospective Clinical Trial

Who this might be right for
Depression in Chronic Hepatitis C
Post Graduate Institute of Medical Education and Research, Chandigarh 385
Early research (Phase 1)Study completedNCT00002116
What this trial is testing

A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS

Who this might be right for
Herpes SimplexHIV Infections
Gilead Sciences 30
Early research (Phase 1)Study completedNCT00000726
What this trial is testing

Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 53
Large-scale testing (Phase 3)Study completedNCT05999435
What this trial is testing

Study of LAU-7b for the Treatment of Long COVID in Adults

Who this might be right for
Long COVID
Laurent Pharmaceuticals Inc. 272
Not applicableStudy completedNCT04719338
What this trial is testing

Occult HCV Infection After DAAD Treatment in Haemodialysis Patients

Who this might be right for
Hepatitis C
Alexandria University 30
Not applicableUnknownNCT05284916
What this trial is testing

Difference in Patterns of Liver Diseases Related Admissions After the Era of DAAS

Who this might be right for
Patternsof Liver Diseasesadmissions After Era of DAAS
Sohag University 200
Testing effectiveness (Phase 2)Study completedNCT01306617
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C InfectionHepatitis CHepatitis C Virus
AbbVie (prior sponsor, Abbott) 50
Testing effectiveness (Phase 2)Study completedNCT01795911
What this trial is testing

Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 165
Not applicableUnknownNCT03897608
What this trial is testing

Quality of Life in Patients With HCV Related Liver Cirrhosis Before and After Direct Acting Antiviral Drugs

Who this might be right for
HCV Related Liver Cirrhosis Direct Acting Antiviral Drugs
Assiut University 50
Testing effectiveness (Phase 2)Study completedNCT00227435
What this trial is testing

Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Not applicableNot Yet RecruitingNCT06926647
What this trial is testing

A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B

Who this might be right for
HBVChronic Hepatitis b
Beijing 302 Hospital 2,000
Testing effectiveness (Phase 2)Study completedNCT04042740
What this trial is testing

Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection

Who this might be right for
Hepatitis C InfectionHIV Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 45
Next Page